These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38953786)

  • 1. Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.
    Li Z; Cheng S; Guo B; Ding L; Liang Y; Shen Y; Li J; Hu Y; Long T; Guo X; Ge J; Gao R; Pibarot P; Zhang B; Xu H; Clavel MA; Wu Y
    Eur Heart J; 2024 Jul; ():. PubMed ID: 38953786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.
    Tung M; Nah G; Tang J; Marcus G; Delling FN
    Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Frailty and the Risk of Degenerative Valvular Heart Disease.
    Guo X; Li Z; Long T; Cheng S; Yang C; Jiang C; Ma H; Gao R; Song C; Huang X; Wu Y
    Innov Aging; 2024; 8(8):igae062. PubMed ID: 39131201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response association between moderate to vigorous physical activity and incident morbidity and mortality for individuals with a different cardiovascular health status: A cohort study among 142,493 adults from the Netherlands.
    Bakker EA; Lee DC; Hopman MTE; Oymans EJ; Watson PM; Thompson PD; Thijssen DHJ; Eijsvogels TMH
    PLoS Med; 2021 Dec; 18(12):e1003845. PubMed ID: 34855764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank.
    Ahn HJ; Choi EK; Rhee TM; Choi J; Lee KY; Kwon S; Lee SR; Oh S; Lip GYH
    Br J Sports Med; 2024 Apr; 58(8):427-434. PubMed ID: 38418213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Vinereanu D; Wang A; Mulder H; Lopes RD; Jansky P; Lewis BS; Gersh BJ; Avezum A; Hanna M; Held C; Wallentin L; Granger CB; Alexander JH
    Heart; 2018 Aug; 104(15):1292-1299. PubMed ID: 29352007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
    Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
    Dreyfus J; Komar M; Attias D; De Bonis M; Ruschitzka F; Popescu BA; Laroche C; Tribouilloy C; Bogachev Prokophiev A; Mizariene V; Bax JJ; Maggioni AP; Messika-Zeitoun D; Vahanian A; Iung B;
    Eur J Heart Fail; 2024 Apr; 26(4):994-1003. PubMed ID: 38374610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.
    Polo-López A; Calatayud J; López-Bueno L; Núñez-Cortés R; Andersen LL; López-Bueno R
    Prog Cardiovasc Dis; 2024 Oct; ():. PubMed ID: 39389333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
    Andell P; Li X; Martinsson A; Andersson C; Stagmo M; Zöller B; Sundquist K; Smith JG
    Heart; 2017 Nov; 103(21):1696-1703. PubMed ID: 28432156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerometer-derived moderate-to-vigorous physical activity and incident nonalcoholic fatty liver disease.
    Liu M; Ye Z; Zhang Y; He P; Zhou C; Yang S; Zhang Y; Gan X; Qin X
    BMC Med; 2024 Sep; 22(1):398. PubMed ID: 39289727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle patterns, genetic susceptibility, and risk of valvular heart disease: a prospective cohort study based on the UK Biobank.
    Jia C; Zeng Y; Huang X; Yang H; Qu Y; Hu Y; Chen W; Yang X
    Eur J Prev Cardiol; 2023 Oct; 30(15):1665-1673. PubMed ID: 37259902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Bioprosthetic Aortic Valve Degeneration.
    Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study.
    Dejby E; Bhatt DL; Skoglund K; Rawshani A; Omerovic E; Redfors B; Myredal A; Petursson P; Angerås O; Gustafsson A; Isaksén D; Herlitz J; Rawshani A
    Sci Rep; 2023 Aug; 13(1):12662. PubMed ID: 37542095
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.